Please login to the form below

Not currently logged in
Email:
Password:

Spravato

This page shows the latest Spravato news and features for those working in and with pharma, biotech and healthcare.

NICE knocks back J&J’s depression nasal spray Spravato

NICE knocks back J&J’s depression nasal spray Spravato

Cites clinical and pricing uncertainty as basis of rejection. Johnson &Johnson’s depression nasal spray Spravato has been hit with a rejection by the UK’s National Institute for Health and ... help more patients have a significant reduction in their

Latest news

More from news
Approximately 4 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...
Why empathy in digital patient recruitment is vital
This is where empathy mapping can be incredibly effective....